Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Crossref
1. A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran
- Mojtaba Jafari
- Parisa Mehdizadeh
- Khosro Keshavarz
- Ehsan Teymourzadeh
- Mohammad Ali Abyazi
- Seyed Moayed Alavian
- Alijanpour Pouria
2. Budget impact analysis of glecaprevir/pibrentasvir treatment for hepatitis C in Iran: a modelling study
- Mojtaba Jafari
- Parisa Mehdizadeh
- Khosro Keshavarz
- Ehsan Teymourzadeh
- Mohammad Ali Abyazi
- Parsa Gholamreza Shirazi